跳至主要内容
临床试验/NCT01162798
NCT01162798已完成不适用

Growth of Preterm Infants Consuming Formula

Société des Produits Nestlé (SPN)16 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
16
主要终点
Growth

研究概览

简要总结

The purpose of this study is to assess growth of preterm infants fed a test formula compared to a standard formula up to the first 4 months of corrected gestational age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 1 Month(Child)
性别
All
接受健康志愿者

入选标准

  • Exclusively formula-fed
  • 28-34 weeks GA at birth
  • Intact GI tract, tolerating full oral feeds
  • Expected to be discharged from the hospital within a minimum of 24 hours, maximum of 5 days

排除标准

  • Severe respiratory disease defined as needing mechanical ventilation at discharge
  • Any significant systemic diseases that could affect growth. This includes cardiac, neurologic, or GI conditions.
  • Major congenital malformation, history of GI surgery, severe postnatal complications
  • Daily or routine diuretic use at time of discharge
  • Receiving more than 10% of daily kcals from food additives such as thickeners
  • Currently participating or having participated in another conflicting clinical trial.

结局指标

主要结局

Growth

时间窗: 4 months

weight gain assessed monthly

次要结局

  • growth, tolerance, morbidity(6 months)
  • Total body bone mineral content and density and body composition, protein status, and metabolic markers(corrected term and 4 months)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

Preterm Infant Growth | 临床试验